November 17, 2022
King & Spalding represents Novartis on landmark ECJ pharma packaging victory
June 22, 2022
Cathay Capital Private Equity and 3i Enter into an Agreement to Sell Havea Group to BC Partners
January 3, 2022
Trulieve Cannabis Corp Wins Dismissal with Prejudice of Securities Fraud Class Action
December 7, 2021
King & Spalding Advises Oaktree Acquisition Corp. II in its Merger with Alvotech
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
December 31, 2020
King & Spalding Advises on Landmark Medicare Reform Bills BENES Act and PAID Act, Both Passed By Congress
July 20, 2016
King & Spalding Advises Jounce Therapeutics on Deal Worth Up to $2.5 Billion
March 24, 2016
King & Spalding Represents GSK on Strategic Collaboration with Miltenyi Biotec
September 17, 2015
King & Spalding Advises Nurix in $150 Million-Plus Drug Collaboration and Option Deal with Celgene
June 8, 2015
King & Spalding Team Advises Five Prime Therapeutics in $131 Million License Agreement with bluebird bio